Medicinova (MNOV) Reports Partnership with BARDA to Repurpose MN-166 (ibudilast) as Medical Countermeasure against Chlorine Gas-induced Lung Injury

Go back to Medicinova (MNOV) Reports Partnership with BARDA to Repurpose MN-166 (ibudilast) as Medical Countermeasure against Chlorine Gas-induced Lung Injury
Medicinova, Inc. (NASDAQ: MNOV) Delayed: 4.09 -0.07 (1.68%)
Previous Close $4.16    52 Week High $10.16 
Open $4.11    52 Week Low $2.91 
Day High $4.17    P/E N/A 
Day Low $4.04    EPS $-0.41 
Volume 132,616